Invention Grant
- Patent Title: Benzimidazole compound and pharmaceutical use thereof
- Patent Title (中): 苯并咪唑化合物及其药物用途
-
Application No.: US12449874Application Date: 2008-02-28
-
Publication No.: US08877779B2Publication Date: 2014-11-04
- Inventor: Masakazu Nakano , Masanori Minoguchi , Tokushi Hanano , Shin-ichiro Ono , Hideki Horiuchi , Koji Teshima
- Applicant: Masakazu Nakano , Masanori Minoguchi , Tokushi Hanano , Shin-ichiro Ono , Hideki Horiuchi , Koji Teshima
- Applicant Address: JP Osaka
- Assignee: Mitsubishi Tanabe Pharma Corporation
- Current Assignee: Mitsubishi Tanabe Pharma Corporation
- Current Assignee Address: JP Osaka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2007-051842 20070301; JP2007-059260 20070308; JP2007-078845 20070326; JP2007-093846 20070330
- International Application: PCT/JP2008/053524 WO 20080228
- International Announcement: WO2008/105497 WO 20080904
- Main IPC: A61K31/445
- IPC: A61K31/445 ; C07D401/04 ; C07D417/14 ; C07D405/14 ; C07D471/04
Abstract:
Provided is an ORL-1 receptor agonist having improved bioavailability based on superior metabolic stability and strong and high selectivity, as compared to conventional compounds. A compound represented by the formula (I) wherein each symbol is as defined in the claims.
Public/Granted literature
- US20100120841A1 BENZIMIDAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF Public/Granted day:2010-05-13
Information query
IPC分类:
